BDNF interacts with endocannabinoids to regulate cocaine-induced synaptic plasticity in mouse midbrain dopamine neurons

Journal of Neuroscience

Volumn 35, Issue 10, 2015, Pages 4469-4481

  Zhong, Peng ^a   Liu, Yong ^a,b   Hu, Ying ^a   Wang, Tong ^a   Zhao, Yong Ping ^a,c   Liu, Qing Song ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

BDNF; Cocaine; Conditioned place preference; DSI; Endocannabinoid; I LTD

Indexed keywords

1 [[6 (3 METHOXYESTRA 1, 3, 5 (10) TRIEN 17BETA YL) AMINO] HEXYL] 1H PYRROLE 2, 5 DIONE; 2, 3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL) PYRROLO [1, 2, 3 DE] [1, 4] BENZOXAZINE; 4 AMINOBUTYRIC ACID RECEPTOR; 4 [BIS (1, 3 BENZODIOXOL 5 YL) HYDROXYMETHYL] 1 PIPERIDINECARBOXYLIC ACID 4 NITROPHENYL ESTER; 7, 8 DIHYDROXYFLAVONE; AMPA RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; COCAINE; DOPAMINE TRANSPORTER; ENDOCANNABINOID; GLUTAMATE RECEPTOR ANTAGONIST; IMMUNOGLOBULIN G; METABOTROPIC RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHOLIPASE C BETA; PHOSPHOLIPASE C GAMMA; TYROSINE 3 MONOOXYGENASE; TYROSINE KINASE RECEPTOR; TYROSINE KINASE RECEPTOR B; UNCLASSIFIED DRUG; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CARBAZOLE DERIVATIVE; DOPAMINE UPTAKE INHIBITOR; ENZYME INHIBITOR; GLUTAMATE RECEPTOR; GT(ROSA)26SOR NON-CODING RNA, MOUSE; INDOLE ALKALOID; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; STAUROSPORINE AGLYCONE; UNTRANSLATED RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; DEPOLARIZATION; DOPAMINERGIC NERVE CELL; ELECTROSTIMULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; GENOTYPE; IMMUNOFLUORESCENCE TEST; INFRARED DIFFERENTIAL INTERFERENCE CONTRAST MICROSCOPY; INHIBITORY POSTSYNAPTIC POTENTIAL; LONG TERM DEPRESSION; MESENCEPHALON; MICROSCOPY; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; GENETICS; IN VITRO STUDY; INSTRUMENTAL CONDITIONING; METABOLISM; PHYSIOLOGY; SYNAPSE; TIME FACTOR; TRANSGENIC MOUSE;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARBAZOLES; COCAINE; CONDITIONING, OPERANT; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DOPAMINERGIC NEURONS; ENDOCANNABINOIDS; ENZYME INHIBITORS; IN VITRO TECHNIQUES; INDOLE ALKALOIDS; MESENCEPHALON; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONAL PLASTICITY; PIPERIDINES; PYRAZOLES; RECEPTORS, GLUTAMATE; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION; SYNAPSES; TIME FACTORS;

EID: 84924463268     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2924-14.2015     Document Type: Article

References (81)

1. Backman CM, Malik N, Zhang Y, Shan L, Grinberg A, Hoffer BJ, Westphal H, Tomac AC (2006) Characterization of a mouse strain expressing Cre recombinase from the 3' untranslated region of the dopamine transporter locus. Genesis 44:383-390.
2. Bahi A, Boyer F, Chandrasekar V, Dreyer JL (2008) Role of accumbens BDNF and TrkB in cocaine-induced psychomotor sensitization, conditioned-place preference, and reinstatement in rats. Psychopharma-cology 199:169-182.
3. Berglind WJ, See RE, Fuchs RA, Ghee SM, Whitfield TW Jr, Miller SW, McGinty JF (2007) A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. Eur J Neurosci 26:757-766.
4. Blankman JL, Simon GM, Cravatt BF (2007) A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14:1347-1356.
5. Borgland SL, Malenka RC, Bonci A (2004) Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J Neurosci 24:7482-7490.
6. Chaperon F, Soubrie P, Puech AJ, Thiebot MH (1998) Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology 135:324-332.
7. Chevaleyre V, Castillo PE (2003) Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38:461-472.
8. Chieng B, Azriel Y, Mohammadi S, Christie MJ (2011) Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. J Physiol 589:3775-3787.
9. Corominas M, Roncero C, Ribases M, Castells X, Casas M (2007) Brain-derived neurotrophic factor and its intracellular signaling pathways in cocaine addiction. Neuropsychobiology 55:2-13.
10. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83-87.
11. De Chiara V, Angelucci F, Rossi S, Musella A, Cavasinni F, Cantarella C, Mataluni G, Sacchetti L, Napolitano F, Castelli M, Caltagirone C, Ber-nardi G, Maccarrone M, Usiello A, Centonze D (2010) Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. J Neurosci 30:8127-8137.
12. De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J, Vanderschuren LJ, Schoffelmeer AN (2001) A cannabinoid mechanism in relapse to cocaine seeking. Nat Med 7:1151-1154.
13. Di Marzo V (2011) Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight. Nat Neurosci 14:9-15.
14. Di Marzo V, Melck D, Bisogno T, De Petrocellis L (1998) Endocannabi-noids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21:521-528.
15. Edwards DA, Kim J, Alger BE (2006) Multiple mechanisms of endocannabinoid response initiation in hippocampus. J Neurophysiol 95:67-75.
16. Gao Y, Vasilyev DV, Goncalves MB, Howell FV, Hobbs C, Reisenberg M, Shen R, Zhang MY, Strassle BW, Lu P, Mark L, Piesla MJ, Deng K, Koura-nova EV, Ring RH, Whiteside GT, Bates B, Walsh FS, Williams G, Panga-los MN, et al. (2010) Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci 30:2017-2024.
17. Gerdeman GL, Ronesi J, Lovinger DM (2002) Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 5:446-451.
18. Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM (2003) It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 26:184-192.
19. Gong R, Ding C, Hu J, Lu Y, Liu F, Mann E, Xu F, Cohen MB, Luo M (2011) Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior. Science 333:1642-1646.
20. Graham DL, Edwards S, Bachtell RK, DiLeone RJ, Rios M, Self DW (2007) Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci 10:1029-1037.
21. Graham DL, Krishnan V, Larson EB, Graham A, Edwards S, Bachtell RK, Simmons D, Gent LM, Berton O, Bolanos CA, DiLeone RJ, Parada LF, Nestler EJ, Self DW (2009) Tropomyosin-related kinase B in the me-solimbic dopamine system: region-specific effects on cocaine reward. Biol Psychiatry 65:696-701.
22. Grimm JW, Lu L, Hayashi T, Hope BT, Su TP, Shaham Y (2003) Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci 23:742-747.
23. Hashimotodani Y, Ohno-Shosaku T, Tsubokawa H, Ogata H, Emoto K, Mae-jima T, Araishi K, Shin HS, Kano M (2005) Phospholipase Cbeta serves as a coincidence detector through its Ca + dependency for triggering retrograde endocannabinoid signal. Neuron 45:257-268.
24. Heifets BD, Castillo PE (2009) Endocannabinoid signaling and long-term synaptic plasticity. Annu Rev Physiol 71:283-306.
25. Hoover HS, Blankman JL, Niessen S, Cravatt BF (2008) Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling. Bioorg Med Chem Lett 18:5838-5841.
26. Houchi H, Babovic D, Pierrefiche O, Ledent C, Daoust M, Naassila M (2005) CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. Neuropsychopharmacology 30:339-349.
27. Huang CC, Yeh CM, Wu MY, Chang AY, Chan JY, Chan SH, Hsu KS (2011) Cocaine withdrawal impairs metabotropic glutamate receptor-dependent long-term depression in the nucleus accumbens. J Neurosci 31:4194-4203.
28. Huang ZJ, Kirkwood A, Pizzorusso T, Porciatti V, Morales B, Bear MF, Maffei L, Tonegawa S (1999) BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 98:739-755.
29. Hyman SE, Malenka RC, Nestler EJ (2006) Neural mechanisms of addiction: the roleof reward-related learning and memory. Annu Rev Neurosci 29:565-598.
30. Jang SW, Liu X, Yepes M, Shepherd KR, Miller GW, Liu Y, Wilson WD, Xiao G, Blanchi B, Sun YE, Ye K (2010) A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci U S A 107:2687-2692.
31. Johnson SW, North RA (1992) Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol 450:455-468.
32. Jones S, Kauer JA (1999) Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area. J Neurosci 19:9780-9787.
33. Jung KM, Mangieri R, Stapleton C, Kim J, Fegley D, Wallace M, Mackie K, Piomelli D (2005) Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol Pharmacol 68:1196-1202.
34. Kauer JA (2004) Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu Rev Physiol 66:447-475.
35. Kim SJ, Kim YS, Yuan JP, Petralia RS, Worley PF, Linden DJ (2003) Activation of the TRPC1 cation channel by metabotropic glutamate receptor mGluR1. Nature 426:285-291.
36. Kreitzer AC, Regehr WG (2001) Retrograde inhibition of presynaptic calcium influxbyendogenous cannabinoidsatexcitatory synapses onto Pur-kinje cells. Neuron 29:717-727.
37. Lemtiri-Chlieh F, Levine ES (2010) BDNF evokes release of endogenous cannabinoids at layer 2/3 inhibitory synapses in the neocortex. J Neuro-physiol 104:1923-1932.
38. Liu QS, Pu L, Poo MM (2005) Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature 437:1027-1031.
39. Liu X, Liu Y, Zhong P, Wilkinson B, Qi J, Olsen CM, Bayer KU, Liu QS (2014) CaMKII activity in the ventral tegmental area gates cocaine-induced synaptic plasticity in the nucleus accumbens. Neuropsychophar-macology 39:989-999.
40. Lobo MK, Covington HE3rd, Chaudhury D, Friedman AK, Sun H, Damez-Werno D, Dietz DM, Zaman S, Koo JW, Kennedy PJ, Mouzon E, Mogri M, Neve RL, Deisseroth K, Han MH, Nestler EJ (2010) Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 330:385-390.
41. Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavón FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF (2009) Selective blockade of 2-arachidonoylglycerol hydrolysis produces canna-binoid behavioral effects. Nat Chem Biol 5:37-44.
42. Lu H, Cheng PL, Lim BK, Khoshnevisrad N, Poo MM (2010) Elevated BDNF after cocaine withdrawal facilitates LTPinmedial prefrontal cortex by suppressing GABA inhibition. Neuron 67:821-833.
43. Lu L, Dempsey J, Liu SY, Bossert JM, Shaham Y (2004) A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci 24:1604-1611.
44. Luongo L, Maione S, Di Marzo V (2014) Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions. Eur J Neurosci 39:401-408.
45. Lupica CR, Riegel AC (2005) Endocannabinoid release from midbrain do-pamine neurons: a potential substrate for cannabinoid receptor antagonist treatmentofaddiction. Neuropharmacology 48:1105-1116.
46. Maejima T, Hashimoto K, Yoshida T, Aiba A, Kano M (2001) Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31:463-475.
47. Maison P, Walker DJ, Walsh FS, Williams G, Doherty P (2009) BDNF regulates neuronal sensitivity to endocannabinoids. Neurosci Lett 467:90-94.
48. Mameli M, Halbout B, Creton C, Engblom D, Parkitna JR, Spanagel R, Lüscher C (2009) Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc. Nat Neurosci 12:1036-1041.
49. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aver-sive memories. Nature 418:530-534.
50. Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O (2000) Cocaine, but not morphine, induces conditioned place preference and sen-sitization to locomotor responses in CB1 knockout mice. Eur J Neurosci 12:4038-4046.
51. McGinty JF, Whitfield TW Jr, Berglind WJ (2010) Brain-derived neu-rotrophic factor and cocaine addiction. Brain Res 1314:183-193.
52. Ohno-Shosaku T, Maejima T, Kano M (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to pre-synaptic terminals. Neuron 29:729-738.
53. Pan B, Hillard CJ, Liu QS (2008a) D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J Neurosci 28:14018-14030.
54. Pan B, Hillard CJ, Liu QS (2008b) Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. J Neurosci 28:1385-1397.
55. Pan B, Wang W, Long JZ, Sun D, Hillard CJ, Cravatt BF, Liu QS (2009) Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) enhances retrograde endocannabinoid signaling. J Pharmacol Exp Ther 331:591-597.
56. Pan B, Zhong P, Sun D, Liu QS (2011) Extracellular signal-regulated kinase signaling inthe ventral tegmental area mediates cocaine-induced synaptic plasticity and rewarding effects. J Neurosci 31:11244-11255.
57. Park H, Poo MM (2013) Neurotrophin regulation of neural circuit development and function. Nat Rev 14:7-23.
58. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev 4:873-884.
59. Piomelli D, Giuffrida A, Calignano A, Rodriguez de Fonseca F (2000) The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 21:218-224.
60. Pu L, Liu QS, Poo MM (2006) BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat Neurosci 9:605-607.
61. Rebecchi MJ, Pentyala SN (2000) Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 80:1291-1335.
62. Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361:1545-1564.
63. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ (2002) Endogenous cannabinoids mediate long-term synaptic depression in the nucleus ac-cumbens. Proc Natl Acad Sci U S A 99:8384-8388.
64. Saal D, Dong Y, Bonci A, Malenka RC (2003) Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37:577-582.
65. Safo PK, Regehr WG (2005) Endocannabinoids control the induction of cerebellar LTD. Neuron 48:647-659.
66. Soria G, Mendizábal V, Touriño C, Robledo P, Ledent C, Parmentier M, Maldonado R, Valverde O (2005) Lack of CB1 cannabinoid receptor impairs cocaine self-administration. Neuropsychopharmacology 30: 1670-1680.
67. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabi-noid that modulates long-term potentiation. Nature 388:773-778.
68. Tanimura A, Yamazaki M, Hashimotodani Y, Uchigashima M, Kawata S, Abe M, Kita Y, Hashimoto K, Shimizu T, Watanabe M, Sakimura K, Kano M (2010) The endocannabinoid 2-arachidonoylglycerol produced by diac-ylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron 65:320-327.
69. Tozzi A, Bengtson CP, Longone P, Carignani C, Fusco FR, Bernardi G, Mer-curi NB (2003) Involvement of transient receptor potential-like channels in responses to mGluR-I activation in midbrain dopamine neurons. Eur J Neurosci 18:2133-2145.
70. Ungless MA, Whistler JL, Malenka RC, Bonci A (2001) Single cocaine expo-sureinvivo induces long-term potentiationindopamine neurons. Nature 411:583-587.
71. Varma N, Carlson GC, Ledent C, Alger BE (2001) Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21:RC188.
72. Walker EM, Bispham JR, Hill SJ (1998) Nonselective effects of the putative phospholipase C inhibitor, U73122, on adenosine A1 receptor-mediated signal transduction events in Chinese hamster ovary cells. Biochem Pharmacol 56:1455-1462.
73. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588-592.
74. Wiskerke J, Pattij T, Schoffelmeer AN, De Vries TJ (2008) The role of CB1 receptors in psychostimulant addiction. Addict Biol 13:225-238.
75. Xi ZX, Gilbert JG, Peng XQ, Pak AC, Li X, Gardner EL (2006) Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. J Neurosci 26:8531-8536.
76. Xi ZX, Spiller K, Pak AC, Gilbert J, Dillon C, Li X, Peng XQ, Gardner EL (2008) Cannabinoid CB1 receptor antagonists attenuate cocaine’s rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropsychopharmacology 33:1735-1745.
77. Yu F, Zhong P, Liu X, Sun D, Gao HQ, Liu QS (2013) Metabotropic glutamate receptor I (mGluR1) antagonism impairs cocaine-induced conditioned place preference via inhibition of protein synthesis. Neuropsychopharmacology 38: 1308-1321.
78. Zhao L, Levine ES (2014) BDNF-endocannabinoid interactions at neocor-tical inhibitory synapses require phospholipase C signaling. J Neuro-physiol 111:1008-1015.
79. Zhong P, Wang W, Yu F, Nazari M, Liu X, Liu QS (2012) Phosphodiesterase 4 inhibition impairs cocaine-induced inhibitory synaptic plasticity and conditioned place preference. Neuropsychopharmacology 37:2377-2387.
80. Zhong P, Liu X, Zhang Z, Hu Y, Liu SJ, Lezama-Ruiz M, Joksimovic M, Liu QS (2014) Cyclin-dependent kinase 5 in the ventral tegmental area regulates depression-related behaviors. J Neurosci 34:6352-6366.
81. Zhu PJ, Lovinger DM (2005) Retrograde endocannabinoid signaling in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala. J Neurosci 25:6199-6207.